Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Butyric Acid | HCID 264 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Reactant | HCID 59025410 | HCID 59025410 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 24882983 | HCID 24882983 | 56% |
Reaction Steps
To the solution of (3aR,7aR)-1-(1,4′-bipiperidin-4-yl)octahydro-2H-benzimidazol-2-one, 0.25 mmol) in dry DMF (3 mL) was added butyric acid (26 mg, 0.3 mmol) followed by HATU (114 mg, 0.3 mmol) and diisopropylethylamine (0.10 mL, 0.5 mmol) and the mixture was stirred at room temperature for 1 h. The reaction was quenched with water (5 mL) and the solvent was removed in vacuo. Dichloromethane (15 mL) was added and washed with saturated NaHCO3 (10 mL) and brine (10 mL), and dried over Na2SO4. The crude product was purified with high pH prep-LCMS to to provide the title compound (53 mg, 56%) as white powder. 1H NMR (400 MHz, METHANOL-D4): δ ppm 0.94 (t, J=7.42 Hz, 3H), 1.25-1.48 (m, 6H), 1.51-1.65 (m, 3H), 1.68 (d, J=11.72 Hz, 1H), 1.74-2.01 (m, 7H), 2.19-2.32 (m, 3H), 2.35 (t, J=7.62 Hz, 2H), 2.55 (t, J=12.11 Hz, 2H), 2.89-3.11 (m, 5H), 3.56-3.69 (m, 1H), 4.01 (d, J=13.28 Hz, 1H), 4.57 (d, J=13.28 Hz, 1H). MS (M+1): 377.2
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07956069B2 |
|---|
| Source dataset | uspto-grants-2011_06 |
|---|
| ORD ID | ord-65fb64cfb1bd4a9d88016273c8063fda |
|---|
| Source note | uspto-grants-2011_06 |
|---|